Oregon BioEvolution Poster: Now available...
We extend a special thank you to the many companies and organizations that are helping to promote
Oregon's biotechnology, medical device and healthcare industry, including Amgen, Economic Development
For Central Oregon, Davis Wright Tremaine, Fred Hutchinson Cancer Research Center, Lease Crutcher Lewis, Merck & Co.,
Oregon Bioscience Association, Oregon Health & Science University, Perkins Coie, Portland Development Commission,
Ratner BioMedical, SAB Architects, Tonkon Torp, ZymoGenetics and others -- sponsors of the
first ever Oregon BioEvolution poster.
Oregon BioEvolution is a one-of-a-kind genealogy chart that illustrates the founding "technology origins" of more
than 100 biotechnology and medical device firms located in the state of Oregon.
 More...
Destination Oregon
Are you considering a move to Oregon? Relocating your business to
Oregon? Starting a company? Or just interested in Oregon?
This section will answer many of your questions regarding the life science industry in Oregon, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- AstraZeneca and POZEN announce PN 400 Phase III study results AstraZeneca and POZEN, co-development partner for the investigational compound PN 400, announced results from two Phase III studies, PN 400-301 and PN 400-302 comparing PN 400 to enteric-coated naproxen 500 mg. These studies were conducted by POZEN under an agreed Special FDA Protocol Assessment.
AstraZeneca December 03, 2008
- Isis Announces survival advantage in prostate cancer study Isis announced that OncoGenex Pharmaceuticals provided positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel and prednisone compared to docetaxel and prednisone alone for first-line treatment of metastatic castrate resistant prostate cancer.
Isis Pharmaceuticals, Inc. December 03, 2008
- MDRNA reports UNA-Modified siRNAs effectively silence gene targets in animal models MDRNA announced positive in vivo efficacy data on its proprietary Unlocked Nucleic Acid siRNAs in animal models, demonstrating up to 90% knockdown of ApoB. In addition, the Company continues to report effective and safe delivery of its Lead Candidate for hypercholesterolemia in animal models.
MDRNA, Inc. December 03, 2008
- OGX-011 shows advantage in prostate cancer compared to standard therapy OncoGenex Pharmaceuticals announced positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel and prednisone compared to docetaxel and prednisone alone for first-line treatment of metastatic castrate resistant prostate cancer.
OncoGenex Pharmaceuticals, Inc. December 03, 2008
- Wyeth submits European marketing authorization application for its 13-Valent Vaccine Wyeth Pharmaceuticals announced that it has submitted a marketing authorization application to the European Medicines Agency for approval to market its investigational 13-valent pneumococcal conjugate vaccine (PCV13) for infants and young children.
Wyeth Pharmaceuticals December 03, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
Surplus Equipent & Supplies for Sale!
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Oregon's BioHistory
Why is there a biotechnology industry in Oregon? Will the industry continue
to grow in Oregon? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Oregon BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Oregon.
More...
BioEvolution Posters
More...
Celebrate Life: World AIDS Day 2008
December 1 is World AIDS Day; a time to celebrate the many lives saved by HIV prevention and treatment programs.
It also serves as a reminder that we all must do more - as individuals, communities, and as world citizens - to fight the spread
of HIV and AIDS.
Around the world, 33 million people are living with HIV with nearly 7,500 new infections occurring each day. An estimated 3
million people are now receiving antiretroviral treatment in low and middle-income countries.
More...
BioFact
(1997) - Battelle predicts Genetaceuticals, the combination of genetic research & pharmaceutical needs will foster an explosion over the next decade in the pharmaceutical industry.
It's a Small World
|
| |
Plant Cells
| |
Science Quote
"Science is a wonderful thing if one does not have to earn one's living at it."
| - |
Albert Einstein
|
|
(1879-1955)
|
|
